drugset / Trial / NCT01338376

Organization Program of DiabEtes INsulIN ManaGement

NCT01338376 ↗

Phase 4 Unknown 1500 enrolled Chinese Diabetes Society
RandomizedParallel-groupOpen-labelTreatment

Summary

Diabetes is a common, costly condition associated with significant morbidity and mortality. Diabetes self-management education, the process of teaching individuals to manage their diabetes, has been considered an important part. The intensive education has the capacity to deliver effective interventions to a large number of people. The investigators may be able to redirect our efforts to diabetes care and education strategies that will have a positive impact on the optimization of glycemic control and the prevention of long-term complications of diabetes, reducing the subsequent human and health care costs.

Timeline

Start
2011-03
Primary completion
2012-03
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Background Scilin®M30 Protein / enzyme biologic 0.3 iu/kg Other
Background Scilin®M30 Protein / enzyme biologic 0.4 iu/kg Other